• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Can Yin-Chai-Xiao-Du decoction be useful of COVID-19? the mechanism research based on network pharmacology

    2020-06-29 07:57:04LuYangNingLiHaiBoHuBinYinGuoJingZhaoFengChanWangXuHuiWangHongWuWangXueChaoLuHuanTianCui
    Traditional Medicine Research 2020年4期

    Lu Yang, Ning Li, Hai-Bo Hu, Bin Yin, Guo-Jing Zhao, Feng-Chan Wang, Xu-Hui Wang, Hong-Wu Wang, Xue-Chao Lu*, Huan-Tian Cui

    Can Yin-Chai-Xiao-Du decoction be useful of COVID-19? the mechanism research based on network pharmacology

    Lu Yang1#, Ning Li2#, Hai-Bo Hu3, Bin Yin3, Guo-Jing Zhao3, Feng-Chan Wang3, Xu-Hui Wang4, Hong-Wu Wang5, Xue-Chao Lu3*, Huan-Tian Cui6*

    1Graduate School, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China;2First Clinical Hospital, Shandong University of Traditional Chinese Medicine, Jinan 250000, China;3Department of Pulmonary Disease in Qingdao Hospital of Traditional Chinese Medicine, Qingdao 266700, China;4College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan 250000, China;5College of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China;6Shandong Provincial Key Laboratory of Animal Cell and Developmental Biology, School of Life Sciences, Shandong University, Qingdao 250100, China.

    : In this study, we preliminarily investigated the mechanism of Yin-Chai-Xiao-Du decoction for the treatment of COVID-19 by the method of network pharmacology.: The potential targets and pathways of Yin-Chai-Xiao-Du decoction for the treatment of COVID-19 were examined using network pharmacology; the ingredient and active targets of Yin-Chai-Xiao-Du decoction were collected from the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform and PharmMapper databases; the COVID-19-related targets were obtained from the online Mendelian inheritance in man, GeneCards, and GeneMANIA databases; the STRING database and Cytoscape were used to build a protein-protein interaction network, and a Network Analyzer tool was used to perform topology analysis to screen for the key ingredients and targets; the ClueGO and KOBAS 3.0 databases were for the enrichment analysis of gene function (Gene Oncology) and gene pathway (Kyoto Encyclopedia of Genes and Genomes); the herb-ingredient-target-pathway network diagram was constructed by Cytoscape.: The core herbs screened by the network pharmacological analysis wereJinyinhua (), Lianqiao (), Chaihu (), Huangqin (), Yinchen (), Guanghuoxiang (), Roudoukou () and Qinghao (). A total of 293 active ingredients were screened by Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform, and the key ingredients were quercetin, kaempferol, isorhamnetin, stigmasterol, beta-sitosterol, and luteolin. Yin-Chai-Xiao-Du decoction has 138 COVID-19-related targets, and the key targets were mitogen-activated protein kinase 3, interleukin-6, tumor necrosis factor, vascular endothelial growth factor A, and CC motif ligand 2. Kyoto Encyclopedia of Genes and Genomes analysis revealed 120 enriched gene pathways, and the key pathways were signaling by interleukins, immune system, cytokine signaling in the immune system, and the signaling pathways of interleukin-17, tumor necrosis factor, and relaxin.: The core herbs of Yin-Chai-Xiao-Du decoction are Jinyinhua (), Lianqiao (), Chaihu (), Huangqin (), Yinchen (), Guanghuoxiang (), Roudoukou () and Qinghao ()The key ingredients are quercetin, kaempferol, isorhamnetin, stigmasterol, and beta-sitosterol; the critical targets are luteolin, interleukin-6, mitogen-activated protein kinase 3, tumor necrosis factor, and CC motif ligand 2; and the core signaling pathways are those mediated by interleukin-17, tumor necrosis factor, and relaxin.

    Coronavirus disease 2019,,,, Cytokine Storm, Tumor necrosis factor, Interleukin-6

    Our current study explored the potential mechanisms of Yin-Chai-Xiao-Du decoction, an empirical formula of traditional Chinese medicine derived from the classic ancient prescription Gan-Lu-Xiao-Du decoction, on COVID-19 and found its core herbs

    The empirical formula Yin-Chai-Xiao-Du decoction has evolved based on the classic ancient prescription of Gan-Lu-Xiao-Du decoction, which was first mentioned in Wei Zhixiu’s() in the Qing Dynasty of China that was released in approximately 1770 C.E. Gan-Lu-Xiao-Du decoction could alleviate fever, cough and fatigue, which were the major clinical outcomes of COVID-19. However, the mechanisms of action of Yin-Chai-Xiao-Du decoction in the treatment of COVID-19 remain unclear.

    Background

    In February 2020, the World Health Organization announced the coronavirus disease 2019 (COVID-19) as a public health emergency of international concern [1], and its main manifestations are fever, dry cough, fatigue, and pharyngalgia. More so, pneumonia, acute respiratory distress syndrome, and septic shock characterized some of the severe cases [2]. According to the latest real-time statistics of the World Health Organization on April 28, 2020, there were 2,924,722 confirmed COVID-19 cases in total globally, with more than 200,000 cumulative death cases. Sadly, symptomatic and supportive treatments are the main methods for the disease as there are no specific drugs currently and the vaccines are under trials [3]. Many scholars have pinned their hopes on antiviral drugs such as redoxivir and chloroquine. Wang et al. showed that redoxivir and chloroquine have considerable antiviral effects in the COVID-19-infected African green monkey kidney cell line VeroE6 in vitro[4]. However, in a randomized clinical trial published on April 20, 2020, in Lancet, redoxivir did not improve the recovery of the COVID-19 patients or decrease mortality compared with the placebo control group [5]. In addition, there is no sufficient clinical evidence for the anti-COVID-19 effect of chloroquine. Moreover, both medications have some adverse effects.

    Multi-ingredient, multi-target, and multi-path characterized the traditional Chinese medicine compound. Network pharmacology is a regular method for investigating the mechanisms of traditional Chinese medicine for treating COVID-19. We can find the relationship between the traditional Chinese medicine decoction and diseases by constructing the ingredient-target-pathway-disease network, identifying the key targets and submodules, and collectively analyzing the biological functions of the key targets and submodules in the network. He [7] showed that the empirical formula Xuebijing injection can treat COVID-19 by regulating the key targets of tumor necrosis factor (TNF), PRKCB, and RELA, and controlling the signaling pathways of NF-κB and hypoxia inducible factor 1. The main active ingredients of the Xiaochaihu decoction can also regulate mitogen-activated protein kinase 3 (MAPK3), Th17, and other pathways; inhibit inflammation; modulate immune function; and reduce lung injury [8].

    Yin-Chai-Xiao-Du decoction is a recommended recipe for patients with severe COVID-19 by the()[11] and is derived from the ancient prescription Gan-Lu-Xiao-Du decoction. Gan-Lu-Xiao-Du decoction was first mentioned in Wei Zhixiu’s() in the Qing Dynasty that was released in approximately 1770 C.E. The prescription was composed of Huangqin (), Yinchen (), Guanghuoxiang (), Lianqiao (), Shichangpu (), Roudoukou (), Bohe (mint), Mutong (), Shegan (blackberry lily), and Chuanbeimu ().In addition, it is commonly used for treating acute infectious diseases [9]. Yin-Chai-Xiao-Du decoction has evolved based on the formula of Gan-Lu-Xiao-Du decoction. It is composed of Chaihu(), Huangqin (), Jinyinhua (), Lianqiao (), Shichangpu (), Yujin (), Guanghuoxiang (), Peilan (),Yinchen (), Roudoukou (), Danggui (), Mudanpi (), Yiyiren (), Shishangbai (), and Gancao (). In clinical application, patients with COVID-19 mainly show a low fever after the fever is reduced. Therefore,() in the original prescription is replaced by Qinghao () to subside the low fever after the fever is reduced. This study reveals the possible molecular mode of action of Yin-Chai-Xiao-Du decoction for treating COVID-19 through network pharmacology (Figure 1).

    Figure 1 The composition chart of Yin-Chai-Xiao-Du decoction

    Materials and methods

    Virtual screening of active ingredients of Yin-Chai-Xiao-Du decoction

    We searched the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (http://ibts.hkbu.edu.hk/lsp/tcmsp.php) using the keywords of,,,,,,,,,,,,,,, andto get the candidate ingredients of Yin-Chai-Xiao-Du decoction. To obtain the active ingredients of Yin-Chai-Xiao-Du decoction, these ingredients were further screened by the criteria of oral bioavailability (OB) ≥ 30% and drug-like (DL) ≥ 0.18 [10].

    Potential target prediction and gene name annotation

    The chemical ingredients of Yin-Chai-Xiao-Du decoction were entered into the PubChem database (https://pubchem.ncbi.nlm.nih.gov/) by name, and the 3D structures were identified and stored in .sdf format. These data were then uploaded to the PharmMapper platform server (http://www.lilab-ecust.cn/pharmmapper/) [11] to complete the target prediction of the chemical composition and obtain the relevant targets of the active ingredients. The UniProt database (https://www.uniprot.org/) was used to standardize the target proteins as per the active ingredients and obtain the gene names as per the targets.

    Screening of disease targets

    The online Mendelian inheritance in man database [12] (http://omim.org/) and GeneCards database [13] (https://www.genecards.org) were searched for relevant targets using the keyword “COVID-19”. Concurrently, the coexpressed gene of severe acute respiratory syndrome coronavirus 2 for the human receptor angiotensin I converting enzyme 2 (ACE2) was identified from GeneMANIA [14] (http://genemania.org/) to obtain the disease-related targets. The Venny platform (version 2.1, http://bioinfogp.cnb.csic.es/tools/venny/) was used to intersect the targets of Yin-Chai-Xiao-Du decoction and the disease and further obtain the targets for the treatment of COVID-19.

    Protein-protein interaction (PPI) network

    Via the STRING database, the PPI was formed by the intersecting targets from drug and disease, and the PPI network was constructed with Cytoscape 3.7.2 (http://www.cytoscape.org/). Then we used the MCODE plugin to perform cluster analysis of the PPI network. Proteins can hardly achieve their biological and physiological functions alone, so the similarly related groups, called protein complexes or functional modules, accomplish specific cellular tasks. MCODE [16]is a clustering algorithm that can quickly detect densely connected areas in a large-scale target network and score the correlation of targets in the module. To select highly related clusters,the parameter K-Core was set at 2, i.e., the identified module contains at least three edges.

    Gene Oncology (GO) genetic biological process analysis

    Cytoscape’s ClueGO plugin was used to perform gene function GO enrichment analysis on the clusters obtained from common targets. The ClueGO parameter: “Homo Sapiens” in the control panel and “GO biological process” in “Ontologies/Pathways” in “ClueGO Settings” were selected, and only GO entries with≤ 0.01 were shown.

    Kyoto Encyclopedia of Genes and Genomes (KEGG) gene pathway enrichment analysis

    The intersecting targets of the herb and disease were imported into the KOBAS 3.0 database (http://kobas.cbi.pku.edu.cn) for pathway analysis. Settings: “Gene Symbol” in “Type” and “Homo Sapiens” in “Species” were selected, “KEGG” was checked,≤ 0.05, and further pathway enrichment analysis was performed on the genes identified in the screen.

    Construction of “herb-ingredient-target-pathway” network

    Cytoscape 3.7.2 was used to construct a network diagram. We first developed the network and property tables of “herb-active-ingredient-key-target-path”, and then imported them into the Cytoscape for drawing. In the output result, the herb, active ingredients, targets, and pathways were shown as colored and shaped nodes. The ingredients and potential targets were connected by edges and so were the target proteins and pathways.

    Results

    Search results of the chemical constituents of Yin-Chai-Xiao-Du decoction

    A total of 1,992 active ingredients were obtained from the screening, including Chaihu () 288, Huangqin () 58, Jinyinhua () 236, Lianqiao () 150, Shichangpu () 105, Yujin () 222, Guanghuoxiang () 94, Peilan () 60, Yinchen () 53, Roudoukou () 71, Danggui () 125, Mudanpi () 55, Yiyiren () 38, Shishangbai () 30, Gancao () 280 and Qinghao () 127. Further, all the chemical constituents found were screened with OB ≥ 30% and DL ≥ 0.18, which revealed 293 active ingredients that met the screening criteria, as shown in Figure 2 and Table 1.

    Search results of the targets of the active ingredients

    The names of the active ingredients identified by the screen were entered into the PubChem database, and the obtained structures of the ingredients were imported into the PharmMapper to predict the targets. A total of 3,758 targets were obtained, whereas 168 targets remained after deduplication. Table 1 shows the ingredients, active ingredients, and targets of herbs identified in the search and screen.

    Searching for disease genes and screening of key targets

    We obtained 1,196 COVID-19 targets from the online Mendelian inheritance in man database, 251 COVID-19 targets from the GeneCards database, and 5,556 ACE2 coexpressed genes from the GeneMANIA. Then, by intersecting the targets of the active ingredients of the herbs with the disease targets, we finally obtained 138 possible targets as per the treatment of fever by Yin-Chai-Xiao-Du decoction. Cytoscape was used to construct the target interaction network of Yin-Chai-Xiao-Du decoction, including 138 nodes and 2,640 edges in the model. The target network model is characterized as the average degree of node connection of 23, the clustering coefficient of 0.554, and the network density of the topological structure of 0.355. As shown in Figure 3 the darker the color and the larger the size, the denser the targets are. Accordingly, interleukin (IL)-6, MAPK3, JUN, TNF, VEGFA, and CC motif ligand 2 (CCL2) had higher degrees and stronger interactions with other proteins (Figure 3).

    Further cluster analysis of 138 nodes was conducted using the MCODE plugin, and six clusters were obtained (Figure 4). An analysis of the biological functions (GO) of the clusters using ClueGO plugin showed that the mechanisms were related to smooth muscle adaptation, positive regulation of cyclase activity, regulation of protein deacetylation, regulation of muscle cell apoptotic process, response to reactive oxygen species, cellular response to chemical stress, and cellular response to oxidative stress, etc.

    Results of KEGG gene pathway enrichment analysis

    Using the KOBAS 3.0 database, 120 enriched pathways were detected and the top 20 were chosen as per the-value. The results showed that the targets were remarkably enriched pathways in terms of multiple signaling pathways of ILs, immune system, cytokine in the immune system, neuroactive ligand-receptor interaction, IL-17, TNF, and relaxin (Figure 5).

    Figure 2 The number of main chemical constituents of each herb in Yin-Chai-Xiao-Du decoction

    Table 1 The number of targets of chemical constituents in Yin-Chai-Xiao-Du decoction

    Figure 3 PPI map of common targets. Each node represents a target. The darker color and larger size indicate a higher degree of nodes, which are more possible to be key targets. The proteins with higher degrees include MAPK3, JUN, TP53, IL-6, TNF, VEGFA, CCL2, and EGF, which all have stronger interactions with other proteins.

    Figure 4 The six clusters in the target network of Yin-Chai-Xiao-Du decoction. Each node represents a target and each edge represents an interaction relationship. The highly correlated nodes are enriched into a subcluster. The darker the color and the larger the size of the node, the higher its degree value is. Each cluster contains at least three edges.

    Figure 5 KEGG enrichment analysis of the targets of Yin-Chai-Xiao-Du decoction. The abscissa is the negative logarithm of the-value, and a longer band means a higher correlation; the ordinate is the name of the KEGG pathway.

    Construction of the herb-ingredient-target-pathway network

    A table of “herb-ingredient-target-pathway” network was developed and imported into Cytoscape 3.7.2 software. The red triangle nodes represent drugs, blue rectangle nodes represent pathways, and green ellipse nodes represent active ingredients. The herb-ingredient-target-pathway of Yin-Chai-Xiao-Du decoction for the treatment of COVID-19 was constructed by the targets with orange rectangle nodes. As shown in the figure, each active ingredient acted on multiple targets. The more connected nodes and the higher correlations, the more likely it is a key ingredient, and it is then at a core position in the mechanisms of Yin-Chai-Xiao-Du decoction for the treatment of COVID-19. After the network analysis, we found that quercetin, kaempferol, isorhamnetin, stigmasterol, beta-sitosterol, and luteolin were the top-ranked core ingredients (Figure 6).

    We selected the ingredients of the top-ranked 10 targets, and the herb-ingredient network constructed by Cytoscape showed that the ingredients with the highest degrees were quercetin, kaempferol, isorhamnetin, stigmasterol, beta-sitosterol, and luteolin. Among them, quercetin and kaempferol were shared by Jinyinhua (), Lianqiao (), Chaihu (), and Qinghao (); stigmasterol and isorhamnetin were shared by Chaihu (), Huangqin () and Qinghao (); luteolin and beta-sitosterol were shared by Jinyinhua () and Lianqiao (); quercetin and isorhamnetin were shared by Yinchen () and Guanghuoxiang (); luteolin and quercetin were shared by Roudoukou () and Lianqiao (). These data suggest that Jinyinhua (), Lianqiao (), Chaihu (), Huangqin (), Guanghuoxiang (), Yinchen (), Roudoukou (), and Qinghao () are the core herbs of Yin-Chai-Xiao-Du decoction for the treatment of COVID-19 (Figure 7).

    Figure 6 Herb-compound-target-pathway network. The red triangle nodes represent herbs, blue rectangle nodes represent pathways, green ellipse nodes represent active ingredients, and orange rectangle nodes represent targets.

    Figure 7 Herb-top 10 ingredients network of Yin-Chai-Xiao-Du decoction. The green nodes represent the herbs, and the blue nodes represent the core ingredients.

    Discussion

    Yin-Chai-Xiao-Du decoction consists of Chaihu (), Huangqin (), Jinyinhua (),Lianqiao (), Shichangpu (), Yujin (), Guanghuoxiang (), Peilan (), Yinchen (), Roudoukou (), Danggui (), Mudanpi (), Yiyiren (), Shishangbai (), Gancao () and Qinghao (). The network pharmacology analysis showed that the key ingredients of Yin-Chai-Xiao-Du decoction for treating COVID-19 are shared by many herbs. For example, stigmasterol and isorhamnetin are shared by Chaihu () and Huangqin (). Stigmasterol shows good anti-inflammatory activity by considerably reducing the expression of IL-1β, IL-6, MCP-1, and COX-2 [17], and synergistic isorhamnetin can inhibit oxidative stress caused by inflammation [18]. Kaempferol is shared by Jinyinhua () andLianqiao (). Kaempferol can scavenge oxygen-free radicals and reduce tissue damage caused by hypoxia [19], and inhibit the expression of the TNF-α and IL-6 inflammatory factors by attenuating the activity of MAPK and AKT pathways, thereby exerting an anti-inflammatory effect [20]. Luteolin and beta-sitosterol are shared by Roudoukou () and Qinghao (). Luteolin can reduce the activity of catalase and superoxide dismutase in lung tissue, thereby reducing the level of oxidative damage and lipid peroxidation and further alleviating acute lung injury in mice [21]. Besides, it can also enhance acute lung injury by inhibiting the MEK/ERK and PI3K/Akt pathways and weakening the activation of neutrophils [22]. Beta-sitosterol has a certain protective effect on acute lung injury caused by lipopolysaccharide. It can improve the oxidative stress response and inhibit the accumulation and release of TNF-α inflammatory factors [23]. In addition, it can also inhibit the infiltration of neutrophils into tissues, reduce the production of β-glucuronidase and superoxide, regulate the complement system, and further regulate immunity system [24]. Furthermore, quercetin is shared by Yinchen () andGuanghuoxiang (). It has the effects of reducing lung inflammation and having antioxidant and antiviral effects. Other studies have shown that it can reduce the expression of TGF-β1, α-SMA, and TNF-α, inhibit the apoptosis of rat alveolar cells, and reduce the inflammation and fibrosis injury of rat lung tissue. Meanwhile, it can enhance pulmonary fibrosis by inhibiting the signal pathway of SphK1/S1P [25–27]. These two effects are synergistic. Jinyinhua (),Lianqiao (), Chaihu (),Huangqin (), Guanghuoxiang (), Yinchen (), Shishangbai (), and Qinghao () are the core herbs for the Yin-Chai-Xiao-Du decoction that have anti-inflammatory, antioxidant, immunoregulation, and lung injury improvement effects.

    Using network pharmacology to screen ingredients, predict targets, and analyze the protein network, we found that the active ingredients of Yin-Chai-Xiao-Du decoction could act on MAPK3, IL6, VEGFA, TNF, and CCL2, which are at the center of the network for treating COVID-19. The network topology analysis showed that the treatment of COVID-19 by Yin-Chai-Xiao-Du decoction involved multiple gene functions and was very complex.

    After the coronavirus invades the lung cells and infects the human body by binding with the S protein on the envelope to the ACE2 receptor [28], it is recognized by the host cell. Subsequently, the body regulates different molecular signaling pathways such as the NF-κB pathway and the MAPK/JNK pathway to trigger inflammation, resulting in the expression of proinflammatory factors and antiviral genes [29–30]. More so, activated immune cells release a large number of cytokines and chemokines, including TNF-α, interleukins (IL-1, IL-6, and IL-12), and chemokines (CCLs), leading to the initiation of inflammatory cytokine storms, which promote the transfer of immune cells to the primary infection site [31]. Then, leukocytes and lymphocytes are recruited and attracted by the boosted cytokines and chemokines to the lesion sites. They are continuously activated and proliferated in attempting to eliminate the virus by releasing inflammatory mediators [32]. Several immune cells and tissue fluids gather in the lungs to regulate the key genes, such as vascular endothelial growth factor, which changes the permeability of the blood vessel and leads to airway obstruction, lung inflammation, and edema. The patient will experience critical conditions such as extreme difficulty in breathing, blood oxygen desaturation, unconsciousness that further leads to multiple organ failure and even death [33]. Therefore, it is speculated that COVID-19 may activate the IL receptor and the MAPK pathway, increase the expression of inflammatory cytokines such as TNF-α and IL-6, and incur a local inflammatory response, therefore resulting in cytokine storms and immune disorders. Yin-Chai-Xiao-Du decoction may play an anti-inflammatory role by inhibiting these proinflammatory cytokines. It can modulate immune functions by influencing the number of immune cells and prevent multiple organ failures caused by endogenous inflammatory mediators to reduce lung damage.

    Meanwhile, COVID-19 patients have congestion and edema of the respiratory tract mucosa caused by a large number of inflammatory cell infiltration, angiectasis, and increased exudation. The large quantity of mucus secretion can be retained in the bronchus and block the normal function of tracheal smooth muscle, producing symptoms of cough, expectoration, and asthma [34]. GO enrichment analysis showed that the targets of Yin-Chai-Xiao-Du decoction were remarkably enriched in the biological processes of smooth muscle adaptation, cell response to reactive oxygen species, and cellular response to chemical stress.

    KEGG enrichment showed that the treatment of COVID-19 by Yin-Chai-Xiao-Du decoction involved multiple pathways such as the anti-inflammatory and immune regulation pathways of IL-17 and TNF. Via corresponding receptors, the IL-17 family transmits signals to activate downstream pathways such as NF-κB and MAPKs. The IL-17 family can induce the expression of antibacterial peptides, cytokines, and chemokines, which plays a vital role in acute and chronic inflammatory reactions [35]. The TNF signaling pathway mainly acts on inhibiting the cytokines in the immune response and inflammatory storm activated by COVID-19, alleviating the immune response, and eliminating the inflammation. TNF can bind to the recombinant human type I TNFR1 and TNFR2, which further mediate inflammation and immune regulation via the cascade reaction of the NF-κB pathway and MAPK [36].

    Furthermore, the KEGG results showed that the core targets were enriched in the relaxin signaling pathway, which acts on COVID-19 mainly through the following four aspects. First, severe COVID-19 cases in the recovery stage can have pulmonary fibrosis for a long time. Specifically, cases with acute respiratory distress syndrome have a poorer prognosis [37]. Mou et al. [38] examined the lung CT of 24 patients with COVID-19. They found that the lesions began to be absorbed and showed fibrosis on the lung CT of the severe and critical patients. Relaxin has anti-fibrotic effects, which have been validated in non-germinal tissue, such as the lung, heart, kidney, and liver tissue [39]. Secondly, relaxin can promote the regeneration of muscle fibers by inhibiting inflammation and fibrosis and participate in the healing of injured ligaments and skeletal muscles [40]. Most patients with COVID-19 are complicated with a concurrent condition of myalgia, which can be relieved by relaxin. More so, clinical studies have shown that the levels of serum myocardial necrosis markers increased regardless of the patient’s condition [41], indicating that COVID-19 may damage cardiac muscle cells. Experiments showed that relaxin could effectively prevent and reverse many adverse reactions in cardiovascular animal models (ischemic/reperfusion injury, myocardial infarction, hypertensive heart disease, and cardiomyopathy), and serelaxin, a recombinant form of relaxin, is in the extended phase III clinical trial for acute heart failure [42]. Finally, Jordan et al. [43] have confirmed that relaxin can prevent the death of brain cells under hypoxia conditions and may have a direct protective effect on nerves, which help to protect the brain tissue of patients with COVID-19 under hypoxia.

    Interestingly, in this network pharmacology study, chlorogenic acid and saikoside were not selected for subsequent analysis because of the low OB value (chlorogenic acid: 11.93% vs. screen criteria: OB ≥ 30) and low DL value (saikoside: 0.09 vs. screen criteria: DL ≥ 0.18). Besides, baicalein and artemisinin were not selected for subsequent analysis because their numbers of targets were 33 and 28, respectively, and ranked 17 and 44, respectively, among all ingredients. Nevertheless, more pharmacological evidence has shown that these ingredients also have anti-inflammatory, antiviral, and immunity regulation effects [44–51]; however, their values for COVID-19 treatment need to be further studied.

    Conclusion

    In summary, the core herbs of Yin-Chai-Xiao-Du decoction for the treatment of COVID-19 are Jinyinhua (), Lianqiao (), Chaihu (), Huangqin (), Yinchen (), Guanghuoxiang (), Roudoukou (), and Qinghao (). The key ingredients include quercetin, kaempferol, isorhamnetin, stigmasterol, beta-sitosterol, and luteolin. The core targets are IL-6, MAPK3, TNF, CCL2, and the core signaling pathways are those of IL-17, TNF, and relaxin.

    1. The World Health Organization has called the 2019-ncov outbreak a public health emergency of international concern. China Health Law 2020, 2802: 34. (Chinese)

    2. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020, 323: 1061–1069.

    3. Li XS, Zhang JX, Zhou XB, et al. Literature review of existing evidence for corona virus disease-19. Eval Anal Drug Use Hosp China 2020, 03: 262–267. (Chinese)

    4. Wang ML, Cao R, Zhang L, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res 2020, 30: 269–271.

    5. Wang Y, Zhang D, Du G, et al. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet 2020, 395: 1569–1578.

    6. Chen YT, Sun JK, Han QY, et al. Advances of studies on remdesivir against coronavirus including SARS-CoV-2. Clin Res Prac 2020, 5: 6–11. (Chinese)

    7. He TM, Duan CC, Li XF, et al. Potential mechanism of Xuebijing injection in treatment of coronavirus pneumonia based on network pharmacology and molecular docking. Chin J Mod Appl Pharm 2020, 37: 398–405. (Chinese)

    8. Yang L, Cui HT, Liu XG, et al. Feasibility of Xiaochaihu decoction on fever induced by coronavirus disease 2019 (COVID-19) based on network pharmacology. Chin Tradit Herb Drugs 2020, 51: 1761–1775. (Chinese)

    9. Li QM. Examples of clinical application of Gan-Lu-Xiao-Du-Dan. Zhejiang J Integr Tradit Chin Western Med 2018, 09: 790–791. (Chinese)

    10. Ru J, Li P, Wang J, et al. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J Cheminform 2014, 6: 13.

    11. Xue J, Shi Y, Li C, et al. Network pharmacology-based prediction of the active ingredients, potential targets, and signaling pathways in compound Lian-Ge granules for treatment of diabetes. J Cell Biochem 2019, 120: 6431–6440.

    12. Obi LG, Malachi G. OMIM (online Mendelian inheritance in man). Dictionary of Bioinformatics and Computational Biology. John Wiley & Sons Ltd., 2014.

    13. Stelzer G, Rosen N, Plaschkes I, et al. The GeneCards suite: from gene data mining to disease genome sequence analyses. Curr Protoc Bioinformatics 2016, 54.

    14. David WF, Donaldson SL, Ovi C, et al. The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res 2010, 38: W214–220.

    15. Szklarcayk D, Gable AL, Lyon D, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res 2019, 47: D607.

    16. Bader GD, Hogue CW. An automated method for finding molecular complexes in large protein interaction networks. BMC Bioinformatics 2003, 4: 2.

    17. Feng SM, Ning K, Shao P, et al. Study on the treatment of acute colitis in mice by pitt-sitosterol and pitosterol. J Chin Cereal Oil Assoc 2018, 33: 80–86, 94. (Chinese)

    18. Wang K, Pang H, Liang CM, et al. Effects of different doses of isorhametin on proliferation of macrophage RAW264.7 in mice with inflammatory injury. Shandong Med J 2018, 39: 48–51. (Chinese)

    19. Lei XQ, Chen A, Liu Y, et al. Research progress on the pharmacological action of kaempferol. Stud Trace Elem Health 2017, 34: 61–62. (Chinese)

    20. Zhou Y, Du BY, Tan YH, et al. Inhibitory effect of kaempferol on proliferation and apoptosis of rat hepatocellular carcinoma cell CBRH7919. J Guangzhou Univ Tradit Chin Med 2010, 27: 250–253. (Chinese)

    21. Kuo MY, Liao MF, Chen FL, et al. Luteolin attenuates the pulmonary inflammatory response involves abilities of antioxidation and inhibition of MAPK and NF-kappaB pathways in mice with endotoxin-induced acute lung injury. Food Chem Toxicol 2011, 49: 2660–2666.

    22. Lee JP, Li YC, Chen HY, et al. Protective effects of luteolin against lipopolysaccharide-induced acute lung injury involves inhibition of MEK/ERK and PI3K/Akt pathways in neutrophils. Acta Pharmacol Sin 2010, 31: 831–838.

    23. Shang ZB, Liu XL, Cheng RQ, et al. Influence of β-sitosterol on gastric mucosal side effect induced by aspirin and its pharmacological functions. Chin J Exp Tradit Med Formul 2016, 22: 148–152. (Chinese)

    24. Navarro A, De LH, Villar A. Anti-inflammatory and immunomodulating properties of a sterol fraction fromfoetens clem. Biol Pharm Bull 2001, 24: 470–473.

    25. Ma N, Li YJ, Fan JP, et al. Research progress on pharmacological action of quercetin. J Liaoning Univ Tradit Chin Med 2018, 20: 221–224. (Chinese)

    26. Wei P, Chen ZB, Wang CE, et al. Protective function and mechanism of quercetin in chronic obstructive pulmonary disease. Chin J Immunol 2019, 35: 2570–2575. (Chinese)

    27. Zhang X, Cai Y, Zhang W, et al. Quercetin ameliorates pulmonary fibrosis by inhibiting SphK1/S1P signaling. Biochem Cell Biol 2018, 96: 742–751.

    28. Zhou P, Yang XL, Wang XG, et al. Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin. Bio Rxiv 2020, 1.

    29. Wang JF, Shao JJ, Chang HY, et al. Advances in research on innate immune recognition receptors of viruses. Chin J Cell Mol Immunol 2009, 25: 1217–1220. (Chinese)

    30. Chow KT, Gale M, Loo YM. RIG-I and other RNAsensors in antiviral immunity. Annual Rev Immunol 2018, 36: 667–694.

    31. Mc NF, Mayer-Barber KD, Sher A, et al. Type I interferons in infectious disease. Nat Rev Immunol 2015, 15: 87–103.

    32. Teijaro JR. Cytokine storms in infectious diseases. Semin Immunopathol 2017, 39: 501–503.

    33. Clark IA,Vissel B. The meteorology of cytokine storms, and the clinical usefulness of this knowledge. Semin Immunopathol 2017, 39: 505–516.

    34. Mejza F, Gnatiuc L, Buist AS, et al. Prevalence and burden of chronic bronchitis symptoms: results from the BOLD study. Eur Respir J 2017, 50: 1700621.

    35. Li XX, Bechara R, Zhao JJ, et al. IL-17 receptor-based signaling and implications for disease. Nat Immunol 2019, 20: 1594–1602.

    36. Zhang Y, Zhou DM, Li W, et al. The expression level of TNF-α in patients with painful diabetic neuropathy. Chin J Lab Diagn 2020, 24: 36–40. (Chinese)

    37. Respiratory Disease Committee of Shanghai Association of Integrative Medicine. Suggestions of integrative medicine treatment on some hot issues about COVID-19. Shanghai J Tradit Chin Med 2020, 54: 6–9. (Chinese)

    38. Mu J, Wang RP, Liu XF, et al. Preliminary discussion for chest CT dynamic findings of COVID-19 patients. Chin Imaging J Integr Tradit Western Med 2020, 18: 116–119. (Chinese)

    39. Samuel CS, Royce SG, Hewitson TD, et al. Anti-fibrotic actions of relaxin. Br J Pharmacol 2017, 174: 962–976.

    40. Dehghan F, Haerian BS, Muniandy S, et al. The effect of relaxin on the musculoskeletal system. Scand J Med Sci Sports 2014, 24: e220–e229.

    41. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020, 323: 1061–1069.

    42. Sarwar M, Du XJ, Dschietzig TB, et al. The actions of relaxin on the human cardiovascular system. Br J Pharmacol 2017, 174: 933–949.

    43. Willcox JM, Summerlee AJ. Relaxin protects astrocytes from hypoxia in vitro. PLoS One 2014, 9: e90864.

    44. Huang L, Tang JL, Huang J, et al. Advances in extraction and application of chlorogenic acid. Res Lab Work Coll Univ 2012, 9: 114–117. (Chinese)

    45. Wu HZ, Luo J, Yin YX, et al. Effects of chlorogeni acid, an active compound activating calcineurin, purified fromon macrophage. Acta Pharmacol Sin 2004, 25: 1685–1689.

    46. Zhu J, Luo C, Wang P, et al. Saikosaponin a mediates the inflammatory response by inhibiting the MAPK and NF-κB pathways in LPS-stimulated RAW 264.7 cells. Exp Ther Med 2013, 5: 1345–1350.

    47. Wan QF, Gu LG, Yin SJ, et al. Protection effect of baicalin on lung injury of mice infected with influenza FM1. China J Tradit Chin Med Pharm 2011, 26: 2818–2851. (Chinese)

    48. Wan QF, Wang H, Han XB, et al. Baicalin inhibits TLR7/MYD88 signaling pathway activation to suppress lung inflammation in mice infected with influenza a virus. Biomed Rep 2014, 2: 437–441.

    49. Wang JX, Tang W, Yang ZS, et al. Suppressive effect of a novel water-soluble artemisinin derivative SM905 on T cell activation and proliferation in vitro and in vivo. Eur J Pharmacol 2007, 564: 211–218.

    50. Khakzad MR, Ganji A, Ariabod V, et al. Artemisinin therapeutic efficacy in the experimental model of multiple sclerosis. Immunopharmacol Immunotoxicol 2017, 39: 348–353.

    51. Wen Y, Pan MM, Lv LL, et al. Artemisinin attenuates tubulointerstitial inflammation and fibrosis via the NF-κB/NLRP3 pathway in rats with 5/6 subtotal nephrectomy. J Cell Biochem 2019, 120: 4291–4300.

    :

    Lu Yang and Ning Li contributed to study concept; Hai-Bo Hu and Bin Yin contributed to study design and performance; Guo-Jing Zhao, Feng-Chan Wang and Xu-Hui Wang contributed to analysis of data; Hong-Wu Wang, Lu Yang and Ning Li contributed to drafting of the paper; Xue-Chao Lu and Huan-Tian Cui contributed to study supervision.

    :

    The authors declare no conflicts of interest.

    :

    This study was supported bythe National Key Research and Development Program (No. 2018YFC1704800) and the Chinese Medicine Standardization Project of State Administration of Traditional Chinese Medicine (No. SATCM-2015-BZ125).

    :

    COVID-19, coronavirus disease 2019; TNF, tumor necrosis factor; OB, oral bioavailability; DL, drug-like; GO, Gene Oncology; KEGG, Kyoto Encyclopedia of Genes and Genomes; MAPK3, mitogen-activated protein kinase 3; ACE2, angiotensin I converting enzyme 2; IL, interleukin; PPI, protein-protein interaction; CCL2, CC motif ligand 2.

    :

    Lu Yang, Ning Li, Hai-Bo Hu, et al. Can Yin-Chai-Xiao-Du decoction be useful of COVID-19? the mechanism research based on network pharmacology. Traditional Medicine Research 2020, 5 (4): 188–200.

    :Rui-Wang Zhao.

    :13 May 2020,

    28 May 2020,

    :09 June 2020.

    #These authors are co-first authors on this work.

    Xue-Chao Lu. Department of Pulmonary Disease in Qingdao Hospital of Traditional Chinese Medicine, No.4 Renmin Road, North District, Qingdao 266700, China. E-mail: hospitalbreathing@163.com; Huan-Tian Cui. Shandong Provincial Key Laboratory of Animal Cell and Developmental Biology, School of Life Sciences, Shandong University, No.72 Binhai Road, Jimo District, Qingdao 250100, China. E-mail: 1762316411@qq.com.

    10.12032/TMR20200601185

    国产伦一二天堂av在线观看| 午夜亚洲福利在线播放| 国产一区在线观看成人免费| 好男人电影高清在线观看| 黄色 视频免费看| 在线观看www视频免费| 亚洲电影在线观看av| 在线观看www视频免费| 亚洲成人久久性| 亚洲精品中文字幕在线视频| 久久香蕉精品热| 欧美不卡视频在线免费观看 | 不卡一级毛片| 又紧又爽又黄一区二区| 一本大道久久a久久精品| 9191精品国产免费久久| 一区二区三区国产精品乱码| 免费一级毛片在线播放高清视频| 两个人看的免费小视频| 久久久久精品国产欧美久久久| 亚洲av电影不卡..在线观看| 国产区一区二久久| 午夜精品久久久久久毛片777| a在线观看视频网站| 精品久久久久久久末码| 久久久久久大精品| 黄色视频不卡| videosex国产| 中文字幕熟女人妻在线| 国产欧美日韩精品亚洲av| 黄片小视频在线播放| 在线观看一区二区三区| 欧美+亚洲+日韩+国产| 久久久久久人人人人人| 老熟妇乱子伦视频在线观看| 亚洲国产日韩欧美精品在线观看 | 在线免费观看的www视频| 人人妻人人澡欧美一区二区| 黄色 视频免费看| 大型黄色视频在线免费观看| 亚洲熟女毛片儿| 久久国产精品影院| 国内精品一区二区在线观看| 亚洲国产日韩欧美精品在线观看 | 五月玫瑰六月丁香| 国产精品久久久久久精品电影| 最好的美女福利视频网| 久久久久久九九精品二区国产 | 99在线视频只有这里精品首页| 欧美人与性动交α欧美精品济南到| 三级毛片av免费| 一卡2卡三卡四卡精品乱码亚洲| 亚洲欧美精品综合久久99| 欧美中文日本在线观看视频| 成年免费大片在线观看| 亚洲免费av在线视频| 国产麻豆成人av免费视频| 操出白浆在线播放| 国产精品美女特级片免费视频播放器 | 欧美绝顶高潮抽搐喷水| 久久久久免费精品人妻一区二区| 色综合婷婷激情| 一级毛片精品| 熟女少妇亚洲综合色aaa.| av超薄肉色丝袜交足视频| 男女视频在线观看网站免费 | 日韩大尺度精品在线看网址| 免费在线观看成人毛片| 免费看十八禁软件| 精品免费久久久久久久清纯| 51午夜福利影视在线观看| 亚洲国产精品成人综合色| 欧美日韩乱码在线| av在线天堂中文字幕| 女生性感内裤真人,穿戴方法视频| 亚洲熟妇中文字幕五十中出| 亚洲精品美女久久久久99蜜臀| 国产午夜精品久久久久久| 丝袜美腿诱惑在线| 久久中文字幕一级| 欧美成人性av电影在线观看| 男女视频在线观看网站免费 | 天天一区二区日本电影三级| 欧美日韩瑟瑟在线播放| 欧美日韩瑟瑟在线播放| 亚洲专区国产一区二区| 国产视频一区二区在线看| 99久久久亚洲精品蜜臀av| 亚洲av成人不卡在线观看播放网| 久久精品人妻少妇| 国产精品久久久av美女十八| 他把我摸到了高潮在线观看| 88av欧美| 国产亚洲欧美在线一区二区| 国内毛片毛片毛片毛片毛片| 欧美zozozo另类| 日本 欧美在线| 嫁个100分男人电影在线观看| 禁无遮挡网站| 国产精品美女特级片免费视频播放器 | 国产午夜精品久久久久久| 国产午夜精品久久久久久| 午夜亚洲福利在线播放| 欧美zozozo另类| 国产真实乱freesex| 97超级碰碰碰精品色视频在线观看| 国产区一区二久久| 国产v大片淫在线免费观看| 国产精品久久电影中文字幕| 成年女人毛片免费观看观看9| 免费看日本二区| 九色国产91popny在线| 亚洲av中文字字幕乱码综合| 757午夜福利合集在线观看| 精品少妇一区二区三区视频日本电影| 国产精品亚洲一级av第二区| 每晚都被弄得嗷嗷叫到高潮| 无遮挡黄片免费观看| 亚洲av美国av| 国产高清视频在线观看网站| 国产黄a三级三级三级人| 亚洲熟妇中文字幕五十中出| 黄色视频,在线免费观看| 岛国在线免费视频观看| 午夜福利在线观看吧| 欧美色视频一区免费| 麻豆成人午夜福利视频| 国产成人一区二区三区免费视频网站| aaaaa片日本免费| 成熟少妇高潮喷水视频| 九色国产91popny在线| 人人妻人人看人人澡| 又黄又粗又硬又大视频| 国产精品98久久久久久宅男小说| 老司机靠b影院| 人人妻人人澡欧美一区二区| 色综合亚洲欧美另类图片| 亚洲国产欧洲综合997久久,| 成在线人永久免费视频| 日本免费a在线| 亚洲五月婷婷丁香| 精品久久蜜臀av无| 在线播放国产精品三级| 亚洲第一电影网av| 国产午夜精品论理片| 亚洲成人免费电影在线观看| 欧美av亚洲av综合av国产av| 丰满人妻一区二区三区视频av | 18禁裸乳无遮挡免费网站照片| 亚洲五月婷婷丁香| e午夜精品久久久久久久| 色av中文字幕| 看免费av毛片| 亚洲最大成人中文| 日韩欧美 国产精品| 精华霜和精华液先用哪个| 88av欧美| 久久久水蜜桃国产精品网| 丁香欧美五月| 日本精品一区二区三区蜜桃| 久久久精品欧美日韩精品| 高清毛片免费观看视频网站| 国产真实乱freesex| 国产精品 欧美亚洲| 看黄色毛片网站| 午夜激情av网站| 午夜视频精品福利| 少妇粗大呻吟视频| 巨乳人妻的诱惑在线观看| 免费在线观看完整版高清| 听说在线观看完整版免费高清| 母亲3免费完整高清在线观看| 麻豆成人午夜福利视频| 美女扒开内裤让男人捅视频| 制服人妻中文乱码| 一级毛片高清免费大全| 国产午夜福利久久久久久| 欧美av亚洲av综合av国产av| 欧美午夜高清在线| 听说在线观看完整版免费高清| www.www免费av| 精品熟女少妇八av免费久了| 丰满人妻熟妇乱又伦精品不卡| 午夜日韩欧美国产| 小说图片视频综合网站| 国产男靠女视频免费网站| 亚洲片人在线观看| videosex国产| 1024手机看黄色片| 国产久久久一区二区三区| 中文字幕高清在线视频| 一级黄色大片毛片| av中文乱码字幕在线| 国产91精品成人一区二区三区| 国内毛片毛片毛片毛片毛片| 国产精品 国内视频| 久久这里只有精品19| 观看免费一级毛片| 在线十欧美十亚洲十日本专区| 一区二区三区高清视频在线| 国产又色又爽无遮挡免费看| 亚洲国产欧美人成| 69av精品久久久久久| 国产真实乱freesex| 99热这里只有精品一区 | 男人的好看免费观看在线视频 | 国产在线观看jvid| 哪里可以看免费的av片| 国模一区二区三区四区视频 | 国产成人欧美在线观看| 日韩大尺度精品在线看网址| 精品不卡国产一区二区三区| av国产免费在线观看| 国产午夜精品久久久久久| 欧美黑人巨大hd| 国产日本99.免费观看| 国产99久久九九免费精品| 黄色成人免费大全| 色噜噜av男人的天堂激情| videosex国产| 一本一本综合久久| www.精华液| 欧美激情久久久久久爽电影| 亚洲 国产 在线| 欧美黑人欧美精品刺激| 久久精品91无色码中文字幕| 久久久久久亚洲精品国产蜜桃av| 久久久久久久久免费视频了| 精品不卡国产一区二区三区| 婷婷精品国产亚洲av在线| 天堂动漫精品| 亚洲五月天丁香| 很黄的视频免费| 真人做人爱边吃奶动态| 日韩精品中文字幕看吧| 波多野结衣高清无吗| 亚洲精品美女久久av网站| 一级片免费观看大全| 狂野欧美激情性xxxx| 亚洲 欧美一区二区三区| 亚洲成人免费电影在线观看| 男女下面进入的视频免费午夜| 亚洲九九香蕉| 久99久视频精品免费| 久久热在线av| 女同久久另类99精品国产91| 男女下面进入的视频免费午夜| 精品久久久久久久毛片微露脸| 给我免费播放毛片高清在线观看| 色av中文字幕| 免费在线观看视频国产中文字幕亚洲| 免费看a级黄色片| 欧美日韩亚洲综合一区二区三区_| 久久香蕉激情| 亚洲在线自拍视频| 久久久久久免费高清国产稀缺| 他把我摸到了高潮在线观看| 国产精品久久久久久人妻精品电影| 无人区码免费观看不卡| 淫妇啪啪啪对白视频| 亚洲成人免费电影在线观看| 国产精品久久久人人做人人爽| 亚洲国产精品sss在线观看| 久久精品影院6| 国产av又大| 亚洲人成网站高清观看| 又紧又爽又黄一区二区| 久久这里只有精品中国| 国产伦人伦偷精品视频| 在线看三级毛片| 色综合婷婷激情| 18禁观看日本| 色综合站精品国产| 麻豆成人午夜福利视频| 久久久精品大字幕| 亚洲熟女毛片儿| 宅男免费午夜| 亚洲精华国产精华精| 日韩欧美在线二视频| 天天一区二区日本电影三级| 午夜影院日韩av| 国产欧美日韩精品亚洲av| 国产欧美日韩一区二区精品| 91麻豆精品激情在线观看国产| 色播亚洲综合网| 亚洲国产精品久久男人天堂| 国产亚洲av高清不卡| 一进一出好大好爽视频| 麻豆av在线久日| 法律面前人人平等表现在哪些方面| av免费在线观看网站| 亚洲精品久久成人aⅴ小说| 老鸭窝网址在线观看| 精品久久久久久久久久久久久| 老司机在亚洲福利影院| 中文字幕人成人乱码亚洲影| 99国产精品一区二区蜜桃av| 国产激情久久老熟女| 国产黄片美女视频| 欧美黑人精品巨大| 中亚洲国语对白在线视频| 级片在线观看| 欧美三级亚洲精品| 宅男免费午夜| 亚洲欧美日韩高清专用| 黄色毛片三级朝国网站| 好男人电影高清在线观看| 久久久国产精品麻豆| 亚洲欧美日韩高清专用| 久久 成人 亚洲| 91字幕亚洲| 嫩草影院精品99| 老司机午夜福利在线观看视频| 特级一级黄色大片| 欧美黑人精品巨大| 99riav亚洲国产免费| 久久热在线av| 两个人的视频大全免费| 19禁男女啪啪无遮挡网站| 无人区码免费观看不卡| 欧美日本视频| 午夜福利18| 精品久久久久久久毛片微露脸| 少妇的丰满在线观看| 岛国在线观看网站| 久久99热这里只有精品18| 一本一本综合久久| 中文字幕高清在线视频| 日本五十路高清| 亚洲九九香蕉| 欧美一级毛片孕妇| 国产黄片美女视频| 久久中文看片网| 国产成人aa在线观看| 熟妇人妻久久中文字幕3abv| 日韩 欧美 亚洲 中文字幕| 亚洲国产欧美一区二区综合| 日韩大尺度精品在线看网址| 日本五十路高清| cao死你这个sao货| 成人18禁高潮啪啪吃奶动态图| 国产午夜福利久久久久久| 视频区欧美日本亚洲| 欧美3d第一页| 白带黄色成豆腐渣| 久久精品国产清高在天天线| 一本一本综合久久| 亚洲国产欧美网| 午夜福利欧美成人| 色精品久久人妻99蜜桃| 国产精品电影一区二区三区| 色在线成人网| 在线观看美女被高潮喷水网站 | 免费看a级黄色片| 最好的美女福利视频网| av免费在线观看网站| 级片在线观看| 色播亚洲综合网| 久久久水蜜桃国产精品网| 一级作爱视频免费观看| 国产1区2区3区精品| 国产精品久久久av美女十八| 亚洲五月婷婷丁香| 亚洲国产日韩欧美精品在线观看 | 日日摸夜夜添夜夜添小说| 午夜福利18| 欧美成人一区二区免费高清观看 | 一本大道久久a久久精品| 他把我摸到了高潮在线观看| 在线观看日韩欧美| 日韩精品中文字幕看吧| 十八禁网站免费在线| 又爽又黄无遮挡网站| 国产午夜福利久久久久久| 在线观看美女被高潮喷水网站 | 亚洲精品国产一区二区精华液| 日本黄色视频三级网站网址| or卡值多少钱| 国内久久婷婷六月综合欲色啪| 午夜视频精品福利| 亚洲av第一区精品v没综合| 午夜精品一区二区三区免费看| 日韩欧美 国产精品| 亚洲aⅴ乱码一区二区在线播放 | 亚洲成人国产一区在线观看| 非洲黑人性xxxx精品又粗又长| 激情在线观看视频在线高清| 色综合站精品国产| 国产精品久久电影中文字幕| 99久久久亚洲精品蜜臀av| cao死你这个sao货| 黄色毛片三级朝国网站| 国产一区二区在线观看日韩 | 老熟妇乱子伦视频在线观看| 黄色视频不卡| 亚洲男人的天堂狠狠| 91字幕亚洲| 一边摸一边抽搐一进一小说| 亚洲国产日韩欧美精品在线观看 | 99精品在免费线老司机午夜| 巨乳人妻的诱惑在线观看| 成人手机av| 亚洲一区二区三区不卡视频| av欧美777| 久99久视频精品免费| 国产精品1区2区在线观看.| 午夜福利免费观看在线| 亚洲国产精品久久男人天堂| 亚洲av成人不卡在线观看播放网| 成在线人永久免费视频| 色综合欧美亚洲国产小说| 午夜福利高清视频| 最近最新免费中文字幕在线| 成人精品一区二区免费| 国产免费av片在线观看野外av| 免费在线观看成人毛片| 国产精品亚洲一级av第二区| 91av网站免费观看| 可以在线观看毛片的网站| 一a级毛片在线观看| 国内精品久久久久久久电影| 熟女电影av网| 国产亚洲精品久久久久5区| 夜夜躁狠狠躁天天躁| 啦啦啦免费观看视频1| 午夜激情福利司机影院| 精品不卡国产一区二区三区| 亚洲人成77777在线视频| xxx96com| 99re在线观看精品视频| 狂野欧美白嫩少妇大欣赏| 国产亚洲精品久久久久久毛片| 极品教师在线免费播放| 91大片在线观看| 村上凉子中文字幕在线| 麻豆国产av国片精品| 曰老女人黄片| 淫秽高清视频在线观看| 亚洲天堂国产精品一区在线| 亚洲av五月六月丁香网| 啦啦啦免费观看视频1| 一本一本综合久久| 婷婷亚洲欧美| 亚洲无线在线观看| 日本三级黄在线观看| 国产三级在线视频| 两性夫妻黄色片| 久久精品亚洲精品国产色婷小说| www.999成人在线观看| 一卡2卡三卡四卡精品乱码亚洲| 亚洲av成人不卡在线观看播放网| 桃红色精品国产亚洲av| 欧美日韩国产亚洲二区| 宅男免费午夜| 色av中文字幕| av中文乱码字幕在线| a在线观看视频网站| 亚洲专区字幕在线| 国产欧美日韩精品亚洲av| 日本三级黄在线观看| 成人三级黄色视频| 制服诱惑二区| 亚洲一区中文字幕在线| 国产一区二区激情短视频| 国产精品一区二区免费欧美| 国产又色又爽无遮挡免费看| 亚洲人成电影免费在线| 国产黄片美女视频| 性色av乱码一区二区三区2| 男男h啪啪无遮挡| 国产高清视频在线观看网站| 欧洲精品卡2卡3卡4卡5卡区| 久久人人精品亚洲av| 日韩有码中文字幕| 中文亚洲av片在线观看爽| 久久精品国产亚洲av高清一级| 9191精品国产免费久久| 亚洲熟妇熟女久久| 中文在线观看免费www的网站 | 亚洲免费av在线视频| 成人国产一区最新在线观看| 嫁个100分男人电影在线观看| 亚洲午夜精品一区,二区,三区| a级毛片a级免费在线| 脱女人内裤的视频| 久久久久久久久久黄片| 亚洲国产中文字幕在线视频| 无遮挡黄片免费观看| bbb黄色大片| 777久久人妻少妇嫩草av网站| av在线天堂中文字幕| 脱女人内裤的视频| 国产精品,欧美在线| 校园春色视频在线观看| 男女午夜视频在线观看| 日本一区二区免费在线视频| 一边摸一边做爽爽视频免费| 久久亚洲真实| 国产精品一区二区三区四区免费观看 | 久久人人精品亚洲av| 精品欧美国产一区二区三| 国产精品亚洲一级av第二区| 亚洲黑人精品在线| 日本熟妇午夜| 我要搜黄色片| 在线观看舔阴道视频| 欧美性猛交黑人性爽| 国产成人av激情在线播放| 国产av一区二区精品久久| 老司机午夜十八禁免费视频| 人妻夜夜爽99麻豆av| 黄片大片在线免费观看| 老熟妇乱子伦视频在线观看| а√天堂www在线а√下载| 黑人操中国人逼视频| 九色成人免费人妻av| 伦理电影免费视频| avwww免费| 老司机福利观看| 男女午夜视频在线观看| 三级毛片av免费| 男人舔奶头视频| 国产成人av教育| 成人国产一区最新在线观看| 国产熟女午夜一区二区三区| 亚洲电影在线观看av| 黄片大片在线免费观看| 一级黄色大片毛片| 免费看十八禁软件| 国产精品免费视频内射| 99国产精品一区二区蜜桃av| 免费在线观看视频国产中文字幕亚洲| 国产精品自产拍在线观看55亚洲| 国产熟女xx| 国产一区二区三区在线臀色熟女| 亚洲av中文字字幕乱码综合| 亚洲精品美女久久久久99蜜臀| 国产在线精品亚洲第一网站| 中文字幕人妻丝袜一区二区| 精品久久久久久久久久免费视频| 国产高清视频在线观看网站| 中文字幕最新亚洲高清| 男女下面进入的视频免费午夜| 成人三级做爰电影| 一a级毛片在线观看| www.精华液| 国产精品香港三级国产av潘金莲| 欧美极品一区二区三区四区| 美女午夜性视频免费| 国产久久久一区二区三区| 久久99热这里只有精品18| 亚洲人成网站高清观看| 十八禁网站免费在线| 日日夜夜操网爽| 深夜精品福利| 黑人欧美特级aaaaaa片| 亚洲18禁久久av| 久久久久久久久中文| 国产精品av久久久久免费| 无限看片的www在线观看| 51午夜福利影视在线观看| 久久久久国产精品人妻aⅴ院| 精品免费久久久久久久清纯| 欧美日韩瑟瑟在线播放| 色在线成人网| 成人av在线播放网站| 欧美一区二区精品小视频在线| 狂野欧美白嫩少妇大欣赏| 久久欧美精品欧美久久欧美| e午夜精品久久久久久久| 少妇人妻一区二区三区视频| 亚洲免费av在线视频| 丁香欧美五月| 蜜桃久久精品国产亚洲av| 亚洲精品久久成人aⅴ小说| 欧美大码av| 长腿黑丝高跟| 真人做人爱边吃奶动态| 听说在线观看完整版免费高清| 天堂av国产一区二区熟女人妻 | 99热6这里只有精品| 欧美日本亚洲视频在线播放| 免费在线观看亚洲国产| 国产亚洲精品第一综合不卡| 特大巨黑吊av在线直播| 男女做爰动态图高潮gif福利片| 黄色丝袜av网址大全| 久久精品国产清高在天天线| 国产在线精品亚洲第一网站| 天堂√8在线中文| 欧美乱码精品一区二区三区| 制服丝袜大香蕉在线| 成人高潮视频无遮挡免费网站| 亚洲精华国产精华精| 国产午夜福利久久久久久| 一进一出抽搐动态| 国产野战对白在线观看| 精品日产1卡2卡| 日韩欧美一区二区三区在线观看| 久久国产精品人妻蜜桃| 99在线人妻在线中文字幕| 亚洲午夜理论影院| 亚洲七黄色美女视频| 国产黄片美女视频| 久久久久九九精品影院| 久久久久久人人人人人| 夜夜夜夜夜久久久久| 一区福利在线观看| 伦理电影免费视频| 天堂√8在线中文| 国产亚洲精品一区二区www| 亚洲黑人精品在线| 妹子高潮喷水视频| 亚洲成人久久爱视频| 亚洲精品一区av在线观看|